This is a randomized, open-label, phase I clinical study evaluating the systemic pharmacokinetics and safety of atropine sulfate eye drops in healthy Chinese volunteers.Three concentrations will be investigated, each concentration group must contain both male and female subjects, and each subject receives only one concentration of atropine sulfate eye drop in this study.~The three treatment arms are:~Atropine sulfate dose A (low concentration)~Atropine sulfate dose B (medium concentration)~Atropine sulfate dose C (high concentration)
To evaluate the systemic pharmacokinetics and the safety of atropine sulfate eye drops in healthy volunteers.